Differences in the induction of cytochrome P450 3A4 by taxane anticancer drugs, docetaxel and paclitaxel, assessed employing primary human hepatocytes

Author： Nallani Srikanth   Goodwin Bryan   Buckley Arthur   Buckley Donna   Desai Pankaj  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.54, Iss.3, 2004-09, pp. : 219-229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Ophiopogon japonicus strains from different cultivation regions exhibit markedly different properties on cytotoxicity, pregnane X receptor activation and cytochrome P450 3A4 induction

By          

Biomedical Reports, Vol. 3, Iss. 3, 2015-01 ,pp. : 430-434

Science Publishers

Access to resources Recommend Favorite

Cytochrome P450 1B1: a novel anticancer therapeutic target

By McFadyen Morag CE   Murray Graeme I  

Future Oncology, Vol. 1, Iss. 2, 2005-04 ,pp. : 259-263

Future Medicine

Access to resources Recommend Favorite

Differential Interactions of Cytochrome P450 3A5 and 3A4 with Chemotherapeutic Agent-Vincristine: A Comparative Molecular Dynamics Study

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 4, 2015-05 ,pp. : 475-483

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of cotreatment with sulforaphane and autophagy modulators on uridine 5'-diphosphoglucuronosyltransferase 1A isoforms and cytochrome P450 3A4 expression in Caco2 human colon cancer cells

By  

Oncology Letters, Vol. 8, Iss. 6, 2014-01 ,pp. : 2407-2416

Spandidos Publications

Access to resources Recommend Favorite

Inhibition of the enzyme activity of cytochrome P450 1A1, 1A2 and 3A4 by fucoxanthin, a marine carotenoid

By    

Oncology Letters, Vol. 6, Iss. 3, 2013-01 ,pp. : 860-864

Spandidos Publications

Access to resources Recommend Favorite